Physician profile
Jeffrey Michael Smith
NPI 1649707506
$6,584.50
in general payments reported to CMS, 2019-2025
16 companies · $5,184 in 2025
The $5,184 reported for 2025 was more than what 93% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $189 · 2022: $231 · 2023: $159 · 2024: $636 · 2025: $5,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,526 · Travel and Lodging: $2,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,525.89 |
| Travel and Lodging | $2,453.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,836.59 | 2025 | Axoguard Ha+ Nerve Protector |
| Abbvie INC. | $1,143.57 | 2024-2025 | |
| Stryker Corporation | $904.03 | 2025 | 1788, Spy-Phi System |
| Acera Surgical, INC. | $586.42 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $418.99 | 2024-2025 | Traumaone, Evo Seeg Electrode |
| Allergan, INC. | $318.04 | 2021-2022 | |
| Mentor Worldwide LLC | $309.80 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Kerecis Limited | $229.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $185.68 | 2019 | |
| Motiva USA, LLC | $134.15 | 2024 | |
| Tela Bio, INC. | $130.35 | 2024 | Ovitex 2s |
| Heron Therapeutics, INC. | $121.86 | 2025 | Aponvie, Zynrelef |
| Medical Device Business Services, INC. | $101.67 | 2022 | |
| Atricure, INC. | $81.36 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Integra Lifesciences Corporation | $44.02 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beutlich Pharmaceuticals LLC | $38.88 | 2025 | Hurri-Freeze |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.